NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054302

Registered date:01/05/2024

Clinical Trial on Artificial Intelligence (AI) Assisted System for Diagnosis of Liver Lipidosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiednon-alcoholic fatty liver
Date of first enrollment2022/04/01
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeAbdominal ultrasound and MRI examinations are performed after consent forms are obtained. Abdominal ultrasound qualitatively and quantitatively evaluates the degree of liver fibrosis and lipidosis, while MRI quantifies and evaluates the amount of fat in the liver.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum100years-old
GenderMale and Female
Include criteria
Exclude criteria1) Patients with tattoos or MRI-unsuitable metal in the body 2) Pregnant or lactating women, or patients who may be pregnant or intend to become pregnant (a pregnancy reaction test should be performed if pregnancy is suspected). 3) Patients with other conditions that may compromise patient safety in the conduct of the study or make it difficult to comply with the study protocol.

Related Information

Contact

public contact
Name Hidemi Unozawa
Address 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba Japan 260-8677
Telephone 0432227171
E-mail unozawa.hidemi@chiba-u.jp
Affiliation Chiba University Hospital gastroenterology
scientific contact
Name Naoya Kato
Address 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba Japan
Telephone 0432227171
E-mail unozawa.hidemi@chiba-u.jp
Affiliation Chiba University Hospital gastroenterology